Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial (Q34391589)

1 August 2017

title

Longterm treatment of irritable bowel syndrome with cimetropium bromide: a double blind placebo controlled clinical trial (English)

1 reference

ORCID Public Data File 2021

1 August 2017

0 references

irritable bowel syndrome

1 reference

Imbimbo BP

1 reference

author name string

Dobrilla G

series ordinal

1 reference

1 August 2017

Piazzi L

series ordinal

1 reference

1 August 2017

Bensi G

series ordinal

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 March 1990

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

355-358

1 reference

Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378284

Psyllium therapy in the irritable bowel syndrome. A double-blind trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378284

Cimetropium: characterization of antimuscarinic and spasmolytic properties

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378284

Irritable bowel syndrome: epidemiology, diagnosis and treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378284

Transverse and sigmoid colon motility in healthy humans: effects of eating and of cimetropium bromide

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378284

Is there a relationship between symptoms of the irritable bowel syndrome and objective measurements of large bowel function? A longitudinal study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378284

Irritable bowel syndrome: prevalence, prognosis and consequences.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378284

Reduction by cimetropium bromide of the colonic motor response to eating in patients with the irritable bowel syndrome.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378284

Controlled treatment trials in the irritable bowel syndrome: a critique.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378284

Confidence intervals rather than P values: estimation rather than hypothesis testing

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378284

Are anticholinergics of use in the irritable colon syndrome?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378284

Relative Potency of the Atropine-Like Effects of A New parasympatholytic Drug, Scopolamine-N-(Cyclopropy 1 Methyl) Bromide and Those of Hyoscine-N-Butyl Bromide

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1378284

Domperidone treatment in the irritable bowel syndrome

6 July 2018

1 reference

12 December 2020

Discontinuous oral absorption of cimetropium bromide, a new antispasmodic drug

1 reference

12 December 2020

Urinary excretion of cimetropium bromide after multiple oral doses

1 reference

12 December 2020

Oral cimetropium bromide, a new antimuscarinic drug, for long-term treatment of irritable bowel syndrome

1 reference

12 December 2020

Cimetropium bromide: in vitro and in vivo evaluation of spasmolytic activity on human and dog colon

1 reference

12 December 2020

Effects of cimetropium bromide on gastrointestinal transit time in patients with irritable bowel syndrome

1 reference

12 December 2020

Treatment of irritable bowel syndrome with lorazepam, hyoscine butylbromide, and ispaghula husk

1 reference

12 December 2020

Timolol Treatment in the Irritable Bowel Syndrome

1 reference

12 December 2020

The treatment of irritable bowel syndrome. Two doses of mebeverine compared

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.31.3.355

1 reference

1 August 2017

1 reference

1 August 2017

1 reference